Download presentation
Presentation is loading. Please wait.
Published byShannon Jocelyn Carson Modified over 6 years ago
1
n-3 Polyunsaturated Fatty Acids After Coronary Artery Bypass Grafting
Umberto Benedetto, MD, PhD, Giovanni Melina, MD, PhD, Roberta di Bartolomeo, MD, Emiliano Angeloni, MD, Davide Sansone, MD, Giulia Falaschi, MD, Fabio Capuano, MD, Cosimo Comito, MD, Antonino Roscitano, MD, Riccardo Sinatra, MD The Annals of Thoracic Surgery Volume 91, Issue 4, Pages (April 2011) DOI: /j.athoracsur Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Adjusted survival curves according to n-3 polyunsaturated fatty acid (PUFAs) supplementation among patients with good (hazard ratio, 0.89; 95% confidence interval, 0.65 to 1.01) and poor ventricular function (hazard ratio, 0.36; 95% confidence interval, 0.17 to 0.76). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Major adverse cardiac and cerebrovascular event-free survival according to n-3 polyunsaturated fatty acid (PUFAs) supplementation among patients with good (hazard ratio, 0.64; 95% confidence interval, 0.41 to 0.92) and poor ventricular function (hazard ratio, 0.68; 95% confidence interval, 0.43 to 0.93). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.